# Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028
Canonical URL: https://biopharmsignal.com/news/EHC/encompass-health-issues-notice-for-partial-redemption-of-its-4-500-senior-notes-due-2028
Ticker: EHC
Company: Encompass Health Corporation
Source: Encompass Health Corporation
Published: 2026-05-14 20:33 EST
Original Source URL: https://investor.encompasshealth.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-09 20:30 EST — [Encompass Health announces date of 2026 second quarter earnings call](https://biopharmsignal.com/news/EHC/encompass-health-announces-date-of-2026-second-quarter-earnings-call-6ef36947) — Source: Encompass Health Corporation
- 2026-06-09 17:00 EST — [Eastside Rehabilitation Hospital now open in Georgia](https://biopharmsignal.com/news/EHC/eastside-rehabilitation-hospital-now-open-in-georgia-cc955c09) — Source: Encompass Health Corporation
- 2026-05-29 12:00 EST — [Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia](https://biopharmsignal.com/news/EHC/encompass-health-to-build-36-bed-inpatient-rehabilitation-hospital-in-bridgeport-west-virginia) — Source: Encompass Health Corporation
- 2026-05-14 20:33 EST — [Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028](https://biopharmsignal.com/news/EHC/encompass-health-issues-notice-for-partial-redemption-of-its-4-500-senior-notes-due-2028) — Source: Encompass Health Corporation
- 2026-05-14 20:15 EST — [Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offering](https://biopharmsignal.com/news/EHC/encompass-health-announces-pricing-of-500-million-of-senior-notes-due-2034-in-a-private-offering) — Source: Encompass Health Corporation
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)